Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
NCT06563193 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2024-08-20
Summary
Overactive bladder is a prevalent urological disorder marked by symptoms such as urinary urgency, increased frequency of urination, and nighttime urination (nocturia). Neurotrophins, including nerve growth factor and brain-derived neurotrophic factor, play crucial roles in the development and function of neurons. Recent research has suggested a possible connection between these neurotrophins and OAB.
This study sought to explore the relationship between urinary levels of NGF and BDNF and the presence of OAB.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
NERVE GROWTH FACTOR
urinary neurotrophins
Sponsors & Collaborators
-
Erzincan Binali Yildirim Universitesi
lead OTHER
Principal Investigators
-
Ozgur EKICI · ErzincanBinaliYildirim
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-08-15
- Primary Completion
- 2025-05-01
- Completion
- 2025-06-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Uroflowmetry and Nocturnal Enuresis
NCT07028645 ·Status: ACTIVE_NOT_RECRUITING
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED
-
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
NCT03817931 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA
-
Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
NCT01435083 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder
NCT02877901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms
NCT04999657 ·Status: COMPLETED ·Phase: NA
-
Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
NCT06408051 ·Status: COMPLETED
-
Bladder Diary for Diagnosing Bladder Oversensitivity
NCT04981015 ·Status: COMPLETED
-
Behavioural Therapy With Checklist for Overactive Bladder
NCT03662893 ·Status: COMPLETED ·Phase: NA
-
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
NCT03251300 ·Status: UNKNOWN ·Phase: PHASE4
-
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder
NCT06024005 ·Status: COMPLETED ·Phase: NA
-
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
NCT05157295 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes
NCT07025642 ·Status: RECRUITING ·Phase: NA
-
Herbal Patch for Overactive Bladder
NCT03532789 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating a Digital Intervention for Overactive Bladder
NCT05170100 ·Status: COMPLETED ·Phase: NA
-
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
NCT00332319 ·Status: TERMINATED ·Phase: PHASE2
-
Ability to Awaken in Nonmonosymptomatic Enuresis
NCT02845648 ·Status: COMPLETED
-
The Role of Urinary ATP in the Diagnosis, Treatment, and Follow-up of Children with Overactive Bladder
NCT06785558 ·Status: COMPLETED ·Phase: NA
-
Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug
NCT01627145 ·Status: UNKNOWN ·Phase: NA
-
Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics
NCT04090190 ·Status: COMPLETED ·Phase: PHASE4
-
Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia Syndrome
NCT05890690 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity
NCT01530620 ·Status: COMPLETED ·Phase: PHASE3